Cargando…

Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study

BACKGROUND: Hypernatremia is a major electrolyte disorder associated with death among critically ill patients. Glucocorticoid therapy may cause hypernatremia in refractory septic shock patients, but the association between glucocorticoid and intensive care unit (ICU)-acquired hypernatremia (IAH) rem...

Descripción completa

Detalles Bibliográficos
Autores principales: Imaizumi, Takahiro, Nakatochi, Masahiro, Fujita, Yoshiro, Yamamoto, Rie, Watanabe, Kennshi, Maekawa, Michitaka, Yamawaka, Taishi, Katsuno, Takayuki, Maruyama, Shoichi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506169/
https://www.ncbi.nlm.nih.gov/pubmed/32960424
http://dx.doi.org/10.1007/s10157-020-01967-9
_version_ 1783584973797720064
author Imaizumi, Takahiro
Nakatochi, Masahiro
Fujita, Yoshiro
Yamamoto, Rie
Watanabe, Kennshi
Maekawa, Michitaka
Yamawaka, Taishi
Katsuno, Takayuki
Maruyama, Shoichi
author_facet Imaizumi, Takahiro
Nakatochi, Masahiro
Fujita, Yoshiro
Yamamoto, Rie
Watanabe, Kennshi
Maekawa, Michitaka
Yamawaka, Taishi
Katsuno, Takayuki
Maruyama, Shoichi
author_sort Imaizumi, Takahiro
collection PubMed
description BACKGROUND: Hypernatremia is a major electrolyte disorder associated with death among critically ill patients. Glucocorticoid therapy may cause hypernatremia in refractory septic shock patients, but the association between glucocorticoid and intensive care unit (ICU)-acquired hypernatremia (IAH) remains unclear. The aim of this study was to clarify whether glucocorticoid administration was associated with IAH. METHODS: This was a nested case–control study using data from an established cohort including 121 IAH cases identified from 1756 patients who were admitted to ICU in a tertiary care facility in Japan. We included patients who were admitted with a normal range of serum sodium concentrations (130–149 mEq/L) from January 1, 2013 to December 31, 2015 and remained in ICU for ≥ 2 days. Hypernatremia was defined as serum sodium concentration ≥ 150 mEq/L. Each case was matched to one control. RESULTS: Multivariable conditional logistic regression revealed high-dose glucocorticoid {odds ratio (OR), 4.15 [95% confidence interval (CI) 1.29–13.4]}, acute kidney injury (AKI) [OR, 2.72 (95% CI 1.31–5.62)], and osmotic diuretics [OR, 3.44 (95% CI 1.41–8.39)] to be significantly associated with IAH. The contents and amounts of fluid infusion were not significantly associated with IAH. There were also significant duration–response effects between duration of glucocorticoid use and IAH; however, pulse glucocorticoid administration was not associated with IAH. CONCLUSION: In this nested case–control study, we demonstrated a significant association between IAH and high-dose glucocorticoid with significant duration–response effects. Serum sodium concentrations should be monitored carefully in critically ill patients administered prolonged high-dose glucocorticoid. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10157-020-01967-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7506169
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Singapore
record_format MEDLINE/PubMed
spelling pubmed-75061692020-09-23 Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study Imaizumi, Takahiro Nakatochi, Masahiro Fujita, Yoshiro Yamamoto, Rie Watanabe, Kennshi Maekawa, Michitaka Yamawaka, Taishi Katsuno, Takayuki Maruyama, Shoichi Clin Exp Nephrol Original Article BACKGROUND: Hypernatremia is a major electrolyte disorder associated with death among critically ill patients. Glucocorticoid therapy may cause hypernatremia in refractory septic shock patients, but the association between glucocorticoid and intensive care unit (ICU)-acquired hypernatremia (IAH) remains unclear. The aim of this study was to clarify whether glucocorticoid administration was associated with IAH. METHODS: This was a nested case–control study using data from an established cohort including 121 IAH cases identified from 1756 patients who were admitted to ICU in a tertiary care facility in Japan. We included patients who were admitted with a normal range of serum sodium concentrations (130–149 mEq/L) from January 1, 2013 to December 31, 2015 and remained in ICU for ≥ 2 days. Hypernatremia was defined as serum sodium concentration ≥ 150 mEq/L. Each case was matched to one control. RESULTS: Multivariable conditional logistic regression revealed high-dose glucocorticoid {odds ratio (OR), 4.15 [95% confidence interval (CI) 1.29–13.4]}, acute kidney injury (AKI) [OR, 2.72 (95% CI 1.31–5.62)], and osmotic diuretics [OR, 3.44 (95% CI 1.41–8.39)] to be significantly associated with IAH. The contents and amounts of fluid infusion were not significantly associated with IAH. There were also significant duration–response effects between duration of glucocorticoid use and IAH; however, pulse glucocorticoid administration was not associated with IAH. CONCLUSION: In this nested case–control study, we demonstrated a significant association between IAH and high-dose glucocorticoid with significant duration–response effects. Serum sodium concentrations should be monitored carefully in critically ill patients administered prolonged high-dose glucocorticoid. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s10157-020-01967-9) contains supplementary material, which is available to authorized users. Springer Singapore 2020-09-22 2021 /pmc/articles/PMC7506169/ /pubmed/32960424 http://dx.doi.org/10.1007/s10157-020-01967-9 Text en © Japanese Society of Nephrology 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Original Article
Imaizumi, Takahiro
Nakatochi, Masahiro
Fujita, Yoshiro
Yamamoto, Rie
Watanabe, Kennshi
Maekawa, Michitaka
Yamawaka, Taishi
Katsuno, Takayuki
Maruyama, Shoichi
Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study
title Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study
title_full Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study
title_fullStr Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study
title_full_unstemmed Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study
title_short Glucocorticoid treatment is associated with ICU-acquired hypernatremia: a nested case–control study
title_sort glucocorticoid treatment is associated with icu-acquired hypernatremia: a nested case–control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7506169/
https://www.ncbi.nlm.nih.gov/pubmed/32960424
http://dx.doi.org/10.1007/s10157-020-01967-9
work_keys_str_mv AT imaizumitakahiro glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy
AT nakatochimasahiro glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy
AT fujitayoshiro glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy
AT yamamotorie glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy
AT watanabekennshi glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy
AT maekawamichitaka glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy
AT yamawakataishi glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy
AT katsunotakayuki glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy
AT maruyamashoichi glucocorticoidtreatmentisassociatedwithicuacquiredhypernatremiaanestedcasecontrolstudy